Europe Pneumococcal Vaccines

At cognitive, a dedicated team has worked on this report. You can initiate the discussion via Book an appointment.

Author By: Supriya Yadav

Our research analyst works closely with Europe Pneumococcal Vaccines market experts to validate gathered data.

Industry Expert: Not Disclosed (NDA)

Historical data 2022–2025. Base Year: 2025. Forecast: 2026–2034.

Data Updated: March 2026

Unique identification number from Cognitive's database.

Report ID: CMR649838
Report Edition: 8th (Europe: Revenue USD Million/Billion )
Report Pages: 250+

Rating: 4.8 | Review: 23

Athenaeum Dashboard, PDF, Excel, MS Word, Cloud Access and AI Assistant.

Format: Athenaeum Dashboard, Digital Link, PDF, EXCEL, MS Word, Cloud Access and Athenaeum AI Assistant

8th Edition published by Cognitive Market Research.

8th Edition 2026 Revenue: USD Million/Billion

Europe Pneumococcal Vaccines Market Analysis 2026

Q: What is Europe Pneumococcal Vaccines market size/share and growth rate?

Europe Pneumococcal Vaccines market size and its growth rate has been provided in the report. The historical period included in the report is from 2021 to 2024, whereas, the report provides forecast data for the years 2025 to 2033. This will help you to in terms of global market share, regional market share, country level market share to understand how the market has been performing in the past and how it is going to perform in the following years. Correspondingly, historical and forecast analysis comprises sales and revenue data of the global Europe Pneumococcal Vaccinesmarket. Market size for UK, Europe, North America, Asia Pacific, Middle East & Africa is also included in the report.

Q: What are the parameters used to analyze market position?

Europe Pneumococcal Vaccines market report has provided PESTEL and Porter analysis to provide insightful information regarding the market scenario. It also provides market attractiveness analysis with an acknowledgment of various factors within the market, including growth rate and market size, as well as outside factors such as access to raw materials, competition, and industry capacity.

Data Timeline	Historical Data: 2022-2025 \| Base Year: 2025 \| Forecast Period: 2026-2034
Vaccine Type Segment Analysis	Pneumococcal Polysaccharide Vaccines, Pneumococcal Conjugate Vaccines
Product Type Segment Analysis	Pneumovax 23, Synflorix, Prevnar 13, Others

Sector Segment Analysis	Public, Private
Distribution Channel Segment Analysis	Pharmacies, Community clinics, Public Health agencies, Others
Country Analysis	United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe

Share your contact details to receive free updated sample copy/pages of the recently published edition of Europe Pneumococcal Vaccines Market Report 2025.

Europe Pneumococcal Vaccines Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

According to Cognitive Market Research, the Europe Pneumococcal Vaccine Market Size was USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.

Preview of Europe Pneumococcal Vaccines Market Revenue

Europe Pneumococcal Vaccines Industry Statistics

Market Size	2021 (A)	2025 (A)	2033 (P)	CAGR
Europe Pneumococcal Vaccines Market Size	xxxx	xxxx	xxxx

Note: A = Actual data, E = Estimated data, P = Projected data.

Europe Pneumococcal Vaccines Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!

Europe Pneumococcal Vaccines Market Report Description

Introduction to the Europe Pneumococcal Vaccine Market

Over the course of the projection period, a moderate expansion of the Europe market is expected. Every year, Europe witnesses around 20,000 cases and 1,000 deaths from invasive pneumococcal disease (IPD)- which can cause pneumonia. To increase the protection against pneumonia, European governments are urging to introduce vaccination programmes for all age groups.
(Source: https://ilcuk.org.uk/european-governments-urged-to-introduce-vaccination-programmes-for-all-ages-to-increase-protection-against-pneumonia/)

Furthermore, the government of Europe is taking multiple initiatives to improve pneumococcal vaccination. The national government adopted a life course approach to pneumococcal vaccination by recommending it for all three groups and adopting a national pneumococcal immunization program.

For instance, the European Commission approves Pfizer’s PREVENAR 20 to help protect infants and children against pneumococcal disease.
(Source: https://www.pfizer.com/news/press-release/press-release-detail/european-commission-approves-pfizers-prevenar-20r-help)

Europe Pneumococcal Vaccines Market Trends And Status Updates:

Europe Market Trends: We have analyzed various aspects of the market, such as consumer behavior, industry practices, technological advancements, economic indicators, competitive landscapes, etc., and included a detailed qualitative analysis under this section of the final deliverable report copy.
Industry Drivers of Europe Pneumococcal Vaccines: A detailed Qualitative analysis with an expert's opinion will help you understand which industry factors are affecting the growth in a positive perspective.
Industry Restraints of Europe Pneumococcal Vaccines: Negative factors that restrict and slow down the market growth are listed under this section and our experts will also help overcome them under the consultation services (Part of the service) Please note: Restraining factors analysis are equally important drivers and trends as our experts can help companies to develop strategies so that they can overcome retrianst's negative impact.
Industry Opportunities of Europe Pneumococcal Vaccines: Our Research team and industry experts have anticipated the growth opportunities and listed them under this section. Market opportunities are expected to open up a growth window for new entrants and a growth channel for existing players. It helps to understand unmet needs or untapped potential in the market. This insight aids in understanding areas where demand has not been fully satisfied or where potential for expansion exists.

Read a Detailed Qualitative analysis of the above report by requesting the free sample pages from Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Pneumococcal Vaccine Market

To sustain the increasing competition and attain new heights in providing healthcare services, companies are leveraging advancements in technology to innovate and launch new products to gain a competitive advantage. Companies are continuously investing in research and development activities to stay upgraded as per the changing consumer preferences, and market demand, and offer quality treatment options.

Top Companies Market Share in Europe Pneumococcal Vaccines Industry: (In no particular order of Rank)

Companies	2022 (A)	2023 (A)	2024 (A)	2025 (A)
Pfizer Inc.	xxxx	xxxx	xxxx	xxxx
GlaxoSmithKline plc	xxxx	xxxx	xxxx	xxxx
Merck & Co. Inc.	xxxx	xxxx	xxxx	xxxx
Serum Institute of India Pvt. Ltd	xxxx	xxxx	xxxx	xxxx
Biological E. Limited	xxxx	xxxx	xxxx	xxxx
Abbott	xxxx	xxxx	xxxx	xxxx
Sanofi Pasteur SA	xxxx	xxxx	xxxx	xxxx
Wyeth Pharmaceuticals LLC	xxxx	xxxx	xxxx	xxxx
Walvax Biotechnology Co. Ltd.	xxxx	xxxx	xxxx	xxxx
Sk Bioscience.	xxxx	xxxx	xxxx	xxxx
Panacea Biotec Limited.	xxxx	xxxx	xxxx	xxxx

Note: A = Actual data, E = Estimated data, P = Projected data.

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Europe Pneumococcal Vaccines Market Segmentation Analysis from 2022 till 2034

The published report edition delivers Europe Market size analysis from 2021 till the forecast period of 2033. We have included analysis of top performing countries such as (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe) and their Market segmentation by Vaccine Type, Product Type, Sector, Distribution Channel , etc. This will help you to understand detailed segment profile, revenue generation, growth patterns, trends, and differences among the each segments.

By Vaccine type, the market is dominated by Pneumococcal Conjugate Vaccines (PCV). These vaccines can protect children from Streptococcus pneumoniae, which is the most common cause of severe bacterial pneumonia among children. It is already been used in the national immunization program of 146 countries as of June 2020. PCV has demonstrated effectiveness in reducing the incidence and severity of pneumonia and other lower respiratory infections in children. PCVs are the vaccines that are generally recommended for infants younger than two years of age as Pneumococcal Polysaccharide Vaccines (PPSV) are comparatively less effective for this age group.

Europe Pneumococcal Vaccines Market Share (%) by Vaccine Type in 2022-2034

Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!

Among all the product types, Prevenar 13 is reported to dominate the pneumococcal vaccine market. Prevenar 13 is a vaccine available as a suspension for injection that contains parts from 13 different types of the bacterium Streptococcus pneumoniae. It is normally used to protect children aged between six weeks and 17 years against invasive disease, pneumonia, and acute otitis media caused by Streptococcus pneumoniae. This vaccine helps the body make its antibodies which protect against such diseases. As the name goes, Prevenar 13 is only capable of protecting against disease caused by thirteen strains of Streptococcus pneumoniae bacteria included in the vaccine. Additionally, as per studies, Prevenar 13 led to an increase in antibody production following booster vaccinations.

Europe Pneumococcal Vaccines Market Share (%) by Product Type in 2022-2034

2022

2026

2034

Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!

Europe Pneumococcal Vaccines Sector Segment Analysis

Public
Private

Europe Pneumococcal Vaccines Distribution Channel Segment Analysis

Based on distribution channels, the market is reported to be dominated by public health agencies. They have the largest hold on the purchases of vaccines made by organizations like GAVI, WHO, UNICEF, and others. These organizations purchase vaccines in bulk quantities and distribute them across the geographies.

GAVI-supported countries immunize more than 215 million children across 60 lower-income countries against pneumococcal disease in 2019.

In the same year, pneumococcal vaccine coverage in Gavi-supported countries was higher than the worldwide average of 49% in 2019.
(Source: https://www.gavi.org/types-support/vaccine-support/pneumococcal)

Pharmacies
Community clinics
Public Health agencies
Others

Europe Pneumococcal Vaccines Country Analysis

In this section we have included market revenue, share, type, application and other segment analysis for each country level. Our team identifies and analyses potential risks associated with operating in each country, including rules and regulations, geopolitical risks, and other market-specific challenges. We estimate historical data and forecast future trends to understand the market's current situation in each country. This analysis helps key players to build strategies to strengthen their foothold in Europe Pneumococcal Vaccines market.

United Kingdom
France
Germany
Italy
Russia
Spain
Sweden
Denmark
Switzerland
Luxembourg
Rest of Europe

The Current Published report Editon on the website includes the following list of countries analysis whereas in case you looking to access any other country or states level data under Europe then please revert us to access the exclusive Europe Pneumococcal Vaccines industry report Edition.

Europe Pneumococcal Vaccines Market Share (%) by Country (2022-2034)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.

Author's Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Europe Pneumococcal Vaccines Market is witnessing significant growth in the near future.

In 2023, the Pneumococcal Polysaccharide Vaccines segment accounted for noticeable share of global Europe Pneumococcal Vaccines Market and is projected to experience significant growth in the near future.

The Pneumovax 23 segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Pfizer Inc. , Merck & Co. Inc. and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Author's Detail

Supriya Yadav

Research Analyst

LinkedIn | Profile | Book Appointment

Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.

Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.

Bio :

As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.

My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.

I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.

Frequently Asked Questions

What is Europe Pneumococcal Vaccines market size/share and growth rate?

Europe Pneumococcal Vaccinesmarket size and its growth rate has been provided in the report. The historical period included in the report is from 2021 to 2024, whereas, the report provides forecast data for the years 2025 to 2033. This will help you to in terms of global market share, regional market share, country level market share to understand how the market has been performing in the past and how it is going to perform in the following years. Correspondingly, historical and forecast analysis comprises sales and revenue data of the global Europe Pneumococcal Vaccinesmarket. Market size for UK, Europe, North America, Asia Pacific, Middle East & Africa is also included in the report.

What are the major factors affecting the Europe Pneumococcal Vaccines market?

The major factors affecting the Europe Pneumococcal Vaccines market in a positive, as well as negative perspective, have been provided with detailed analysis in the report. This segment has encompassed drivers, opportunities, and challenges faced by the industry. This will help you to understand the major factors impacting Europe Pneumococcal Vaccines market trends and develop your business strategy accordingly.

Who are the top manufacturers of Europe Pneumococcal Vaccines? List of Europe Pneumococcal Vaccines Companies and there market trend or market share?

Major manufacturers or list of Europe Pneumococcal Vaccines manufacturers 2024 involved in the market have been profiled in the report along with their business strategies, recent developments, SWOT analysis, business overview, and market Trend from the year 2021-2024. Europe Pneumococcal Vaccines Companies such as Pfizer Inc., GlaxoSmithKline plc, Merck & Co. Inc., Serum Institute of India Pvt. Ltd, Biological E. Limited, Abbott, Sanofi Pasteur SA, Wyeth Pharmaceuticals LLC, Walvax Biotechnology Co. Ltd., Sk Bioscience., Panacea Biotec Limited. are part of the final deliverable document along with the same we can provide data for 2nd, 3rd, start-up level companies data and strategies as well. This will help you to understand the competitive analysis of the market and how other players are performing in the market. This detailed competitive analysis will help you to strategize your business accordingly and will keep you one step ahead. A quantitative and qualitative analysis of the main players in the Europe Pneumococcal Vaccines market is introduced, from the perspective of sales, revenue and price.

Which segments are covered under Europe Pneumococcal Vaccines market segments analysis?

Under Europe Pneumococcal Vaccines market segments analysis Vaccine Type, Product Type, Sector. It provides detailed insights on each type and application. Further, it provides which sub-segment is dominating the Europe Pneumococcal Vaccines market along with its reason. Additionally, the Europe Pneumococcal Vaccines market report will help you to analyze which sub-segment is fastest-growing during the forecast period.

What has been the impact of COVID-19 on the Europe Pneumococcal Vaccines market?

After the analysis of the complete market, the report has provided how the COVID-19 pandemic has affected the market. All the parameters have covered the overall impact of COVID -19 on the market value, market trend & growth of the market, and how the major players in the particular market are adopting these changes. This will help you to understand the overall optimistic, pessimistic, and neutral effects of the coronavirus pandemic on the Europe Pneumococcal Vaccines market.

How the Europe Pneumococcal Vaccines market performed till 2023 and how will it perform in the following years?

The Europe Pneumococcal Vaccines market has been analyzed thoroughly and has estimated the parameters which have affected the market in the historical period as well as how the market is going to perform in the following years. This will provide a complete market scenario and help you to strategize your next move accordingly to the Europe Pneumococcal Vaccines market Share.

Which region is expected to hold the highest market share in the Europe Pneumococcal Vaccines market?

The report gives an exhaustive investigation of the Europe Pneumococcal Vaccines market at country & regional levels, and provides an analysis of the industry trends in each of the regions, from sales, revenue, and consumption. It will help you to understand which region is dominating the market and is expected to grow significantly in the following years. The regional analysis will help you in strategizing the expansion of business.

What are the parameters used to analyze market position?

Europe Pneumococcal Vaccinesmarket report has provided PESTEL and Porter analysis to provide insightful information regarding the market scenario. It also provides market attractiveness analysis with an acknowledgment of various factors within the market, including growth rate and market size, as well as outside factors such as access to raw materials, competition, and industry capacity.

How to order Full Report or Sample pages of the Europe Pneumococcal Vaccines market?

The sample report for the Europe Pneumococcal Vaccines Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.

Reviews

No reviews yet. Be the first to review!

Europe Pneumococcal Vaccines Market Report Table of Content

Table of Content differs accordign to the user License selction. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section's Or chapter's from the report. Specific section's of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).

Report Scope

Vaccine Type	Pneumococcal Polysaccharide Vaccines, Pneumococcal Conjugate Vaccines
Product Type	Pneumovax 23, Synflorix, Prevnar 13, Others
Sector	Public, Private
Distribution Channel	Pharmacies, Community clinics, Public Health agencies, Others
List of Competitors	Pfizer Inc., GlaxoSmithKline plc, Merck & Co. Inc., Serum Institute of India Pvt. Ltd, Biological E. Limited, Abbott, Sanofi Pasteur SA, Wyeth Pharmaceuticals LLC, Walvax Biotechnology Co. Ltd., Sk Bioscience., Panacea Biotec Limited.

Expand All

Chapter 1 2026 Geopolitical Outlook - Europe Pneumococcal Vaccines Market Detailed Analysis

1.1 Global Power Realignment & Strategic Alliances
1.2 Geopolitical Risk Landscape & Conflict Hotspots
1.3 International Trade Relations & Market Access Environment
1.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
1.5 Supply Chain Resilience, Localization & Resource Nationalism
1.6 Technology Sovereignty & Digital Geopolitics
1.7 Strategic Implications for Investment, Growth & Market Entry

This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy

Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis

2.1 Competitive Landscape Disruption & Strategic Shifts
2.2 AI-Driven Transformation of Industry Value Chain
2.3 Evolution of Business Models & Revenue Streams
2.4 Operational Efficiency & Cost Structure Transformation
2.5 Product, Service & Innovation Acceleration
2.6 Customer Behavior & Demand Evolution
2.7 Future Outlook: AI-Led Market Evolution & Strategic Implications

This chapter will help you gain Europe Market Analysis of Europe Pneumococcal Vaccines. Further deep in this chapter, you will be able to review Europe Europe Pneumococcal Vaccines Market Split by various segments and Country Split.

Chapter 3 Europe Market Analysis

3.1 Europe Europe Pneumococcal Vaccines Market Outlook
- 3.1.1 Europe Europe Pneumococcal Vaccines Market Size 2022 - 2034
- 3.1.2 Europe Europe Pneumococcal Vaccines Market Size By Country 2022 - 2034
- 3.1.3 Europe Europe Pneumococcal Vaccines Market Size by Vaccine Type 2022 - 2034
  - 3.1.3.1 Europe Pneumococcal Polysaccharide Vaccines Market Size
  - 3.1.3.2 Europe Pneumococcal Conjugate Vaccines Market Size
- 3.1.4 Europe Europe Pneumococcal Vaccines Market Size by Product Type 2022 - 2034
  - 3.1.4.1 Europe Pneumovax 23 Market Size
  - 3.1.4.2 Europe Synflorix Market Size
  - 3.1.4.3 Europe Prevnar 13 Market Size
  - 3.1.4.4 Europe Others Market Size
- 3.1.5 Europe Europe Pneumococcal Vaccines Market Size by Sector 2022 - 2034
  - 3.1.5.1 Europe Public Market Size
  - 3.1.5.2 Europe Private Market Size
- 3.1.6 Europe Europe Pneumococcal Vaccines Market Size by Distribution Channel 2022 - 2034
  - 3.1.6.1 Europe Pharmacies Market Size
  - 3.1.6.2 Europe Community clinics Market Size
  - 3.1.6.3 Europe Public Health agencies Market Size
  - 3.1.6.4 Europe Others Market Size

Chapter 4 United Kingdom Market Analysis

4.1 United Kingdom Europe Pneumococcal Vaccines Market Size 2022 - 2034
4.2 United Kingdom Europe Pneumococcal Vaccines Market Size by Vaccine Type 2022 - 2034
4.3 United Kingdom Europe Pneumococcal Vaccines Market Size by Product Type 2022 - 2034
4.4 United Kingdom Europe Pneumococcal Vaccines Market Size by Sector 2022 - 2034
4.5 United Kingdom Europe Pneumococcal Vaccines Market Size by Distribution Channel 2022 - 2034

Chapter 5 France Market Analysis

5.1 France Europe Pneumococcal Vaccines Market Size 2022 - 2034
5.2 France Europe Pneumococcal Vaccines Market Size by Vaccine Type 2022 - 2034
5.3 France Europe Pneumococcal Vaccines Market Size by Product Type 2022 - 2034
5.4 France Europe Pneumococcal Vaccines Market Size by Sector 2022 - 2034
5.5 France Europe Pneumococcal Vaccines Market Size by Distribution Channel 2022 - 2034

Chapter 6 Germany Market Analysis

6.1 Germany Europe Pneumococcal Vaccines Market Size 2022 - 2034
6.2 Germany Europe Pneumococcal Vaccines Market Size by Vaccine Type 2022 - 2034
6.3 Germany Europe Pneumococcal Vaccines Market Size by Product Type 2022 - 2034
6.4 Germany Europe Pneumococcal Vaccines Market Size by Sector 2022 - 2034
6.5 Germany Europe Pneumococcal Vaccines Market Size by Distribution Channel 2022 - 2034

Chapter 7 Italy Market Analysis

7.1 Italy Europe Pneumococcal Vaccines Market Size 2022 - 2034
7.2 Italy Europe Pneumococcal Vaccines Market Size by Vaccine Type 2022 - 2034
7.3 Italy Europe Pneumococcal Vaccines Market Size by Product Type 2022 - 2034
7.4 Italy Europe Pneumococcal Vaccines Market Size by Sector 2022 - 2034
7.5 Italy Europe Pneumococcal Vaccines Market Size by Distribution Channel 2022 - 2034

Chapter 8 Russia Market Analysis

8.1 Russia Europe Pneumococcal Vaccines Market Size 2022 - 2034
8.2 Russia Europe Pneumococcal Vaccines Market Size by Vaccine Type 2022 - 2034
8.3 Russia Europe Pneumococcal Vaccines Market Size by Product Type 2022 - 2034
8.4 Russia Europe Pneumococcal Vaccines Market Size by Sector 2022 - 2034
8.5 Russia Europe Pneumococcal Vaccines Market Size by Distribution Channel 2022 - 2034

Chapter 9 Spain Market Analysis

9.1 Spain Europe Pneumococcal Vaccines Market Size 2022 - 2034
9.2 Spain Europe Pneumococcal Vaccines Market Size by Vaccine Type 2022 - 2034
9.3 Spain Europe Pneumococcal Vaccines Market Size by Product Type 2022 - 2034
9.4 Spain Europe Pneumococcal Vaccines Market Size by Sector 2022 - 2034
9.5 Spain Europe Pneumococcal Vaccines Market Size by Distribution Channel 2022 - 2034

Chapter 10 Sweden Market Analysis

10.1 Sweden Europe Pneumococcal Vaccines Market Size 2022 - 2034
10.2 Sweden Europe Pneumococcal Vaccines Market Size by Vaccine Type 2022 - 2034
10.3 Sweden Europe Pneumococcal Vaccines Market Size by Product Type 2022 - 2034
10.4 Sweden Europe Pneumococcal Vaccines Market Size by Sector 2022 - 2034
10.5 Sweden Europe Pneumococcal Vaccines Market Size by Distribution Channel 2022 - 2034

Chapter 11 Denmark Market Analysis

11.1 Denmark Europe Pneumococcal Vaccines Market Size 2022 - 2034
11.2 Denmark Europe Pneumococcal Vaccines Market Size by Vaccine Type 2022 - 2034
11.3 Denmark Europe Pneumococcal Vaccines Market Size by Product Type 2022 - 2034
11.4 Denmark Europe Pneumococcal Vaccines Market Size by Sector 2022 - 2034
11.5 Denmark Europe Pneumococcal Vaccines Market Size by Distribution Channel 2022 - 2034

Chapter 12 Switzerland Market Analysis

12.1 Switzerland Europe Pneumococcal Vaccines Market Size 2022 - 2034
12.2 Switzerland Europe Pneumococcal Vaccines Market Size by Vaccine Type 2022 - 2034
12.3 Switzerland Europe Pneumococcal Vaccines Market Size by Product Type 2022 - 2034
12.4 Switzerland Europe Pneumococcal Vaccines Market Size by Sector 2022 - 2034
12.5 Switzerland Europe Pneumococcal Vaccines Market Size by Distribution Channel 2022 - 2034

Chapter 13 Luxembourg Market Analysis

13.1 Luxembourg Europe Pneumococcal Vaccines Market Size 2022 - 2034
13.2 Luxembourg Europe Pneumococcal Vaccines Market Size by Vaccine Type 2022 - 2034
13.3 Luxembourg Europe Pneumococcal Vaccines Market Size by Product Type 2022 - 2034
13.4 Luxembourg Europe Pneumococcal Vaccines Market Size by Sector 2022 - 2034
13.5 Luxembourg Europe Pneumococcal Vaccines Market Size by Distribution Channel 2022 - 2034

Chapter 14 Rest of Europe Market Analysis

14.1 Rest of Europe Europe Pneumococcal Vaccines Market Size 2022 - 2034
14.2 Rest of Europe Europe Pneumococcal Vaccines Market Size by Vaccine Type 2022 - 2034
14.3 Rest of Europe Europe Pneumococcal Vaccines Market Size by Product Type 2022 - 2034
14.4 Rest of Europe Europe Pneumococcal Vaccines Market Size by Sector 2022 - 2034
14.5 Rest of Europe Europe Pneumococcal Vaccines Market Size by Distribution Channel 2022 - 2034

This chapter provides an in-depth analysis of the market share among key competitors of Europe Pneumococcal Vaccines. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.

Chapter 15 Competitor Analysis (Subject to Data Availability (Private Players))

15.1 Top Competitors Analysis
- (Subject to Data Availability (Private Players))
  
  15.1.1 Europe Europe Pneumococcal Vaccines Market Revenue and Share by Key Players
- 15.1.2 Top Players Ranking 2024
- 15.1.3 New Product Launch Analysis
- 15.1.4 Industry Mergers and Acquisition Analysis
15.2 Company Profile (Data Subject to Availability) Sample Format
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  15.2.1 Pfizer Inc.
  - 15.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 15.2.1.2 Business Overview
  - 15.2.1.3 Financials (Subject to data availability)
  - 15.2.1.4 R&D Investment (Subject to data availability)
  - 15.2.1.5 Product Types Specification
  - 15.2.1.6 Business Strategy
  - 15.2.1.7 Recent Developments
  - 15.2.1.8 Management Change
  - 15.2.1.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  15.2.2 GlaxoSmithKline plc
  - 15.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 15.2.2.2 Business Overview
  - 15.2.2.3 Financials (Subject to data availability)
  - 15.2.2.4 R&D Investment (Subject to data availability)
  - 15.2.2.5 Product Types Specification
  - 15.2.2.6 Business Strategy
  - 15.2.2.7 Recent Developments
  - 15.2.2.8 Management Change
  - 15.2.2.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  15.2.3 Merck & Co. Inc.
  - 15.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 15.2.3.2 Business Overview
  - 15.2.3.3 Financials (Subject to data availability)
  - 15.2.3.4 R&D Investment (Subject to data availability)
  - 15.2.3.5 Product Types Specification
  - 15.2.3.6 Business Strategy
  - 15.2.3.7 Recent Developments
  - 15.2.3.8 Management Change
  - 15.2.3.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  15.2.4 Serum Institute of India Pvt. Ltd
  - 15.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 15.2.4.2 Business Overview
  - 15.2.4.3 Financials (Subject to data availability)
  - 15.2.4.4 R&D Investment (Subject to data availability)
  - 15.2.4.5 Product Types Specification
  - 15.2.4.6 Business Strategy
  - 15.2.4.7 Recent Developments
  - 15.2.4.8 Management Change
  - 15.2.4.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  15.2.5 Biological E. Limited
  - 15.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 15.2.5.2 Business Overview
  - 15.2.5.3 Financials (Subject to data availability)
  - 15.2.5.4 R&D Investment (Subject to data availability)
  - 15.2.5.5 Product Types Specification
  - 15.2.5.6 Business Strategy
  - 15.2.5.7 Recent Developments
  - 15.2.5.8 Management Change
  - 15.2.5.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  15.2.6 Abbott
  - 15.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 15.2.6.2 Business Overview
  - 15.2.6.3 Financials (Subject to data availability)
  - 15.2.6.4 R&D Investment (Subject to data availability)
  - 15.2.6.5 Product Types Specification
  - 15.2.6.6 Business Strategy
  - 15.2.6.7 Recent Developments
  - 15.2.6.8 Management Change
  - 15.2.6.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  15.2.7 Sanofi Pasteur SA
  - 15.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 15.2.7.2 Business Overview
  - 15.2.7.3 Financials (Subject to data availability)
  - 15.2.7.4 R&D Investment (Subject to data availability)
  - 15.2.7.5 Product Types Specification
  - 15.2.7.6 Business Strategy
  - 15.2.7.7 Recent Developments
  - 15.2.7.8 Management Change
  - 15.2.7.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  15.2.8 Wyeth Pharmaceuticals LLC
  - 15.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 15.2.8.2 Business Overview
  - 15.2.8.3 Financials (Subject to data availability)
  - 15.2.8.4 R&D Investment (Subject to data availability)
  - 15.2.8.5 Product Types Specification
  - 15.2.8.6 Business Strategy
  - 15.2.8.7 Recent Developments
  - 15.2.8.8 Management Change
  - 15.2.8.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  15.2.9 Walvax Biotechnology Co. Ltd.
  - 15.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 15.2.9.2 Business Overview
  - 15.2.9.3 Financials (Subject to data availability)
  - 15.2.9.4 R&D Investment (Subject to data availability)
  - 15.2.9.5 Product Types Specification
  - 15.2.9.6 Business Strategy
  - 15.2.9.7 Recent Developments
  - 15.2.9.8 Management Change
  - 15.2.9.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  15.2.10 Sk Bioscience.
  - 15.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 15.2.10.2 Business Overview
  - 15.2.10.3 Financials (Subject to data availability)
  - 15.2.10.4 R&D Investment (Subject to data availability)
  - 15.2.10.5 Product Types Specification
  - 15.2.10.6 Business Strategy
  - 15.2.10.7 Recent Developments
  - 15.2.10.8 Management Change
  - 15.2.10.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  15.2.11 Panacea Biotec Limited.
  - 15.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 15.2.11.2 Business Overview
  - 15.2.11.3 Financials (Subject to data availability)
  - 15.2.11.4 R&D Investment (Subject to data availability)
  - 15.2.11.5 Product Types Specification
  - 15.2.11.6 Business Strategy
  - 15.2.11.7 Recent Developments
  - 15.2.11.8 Management Change
  - 15.2.11.9 S.W.O.T Analysis

This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.

Chapter 16 Qualitative Analysis (Subject to Data Availability)

16.1 Market Drivers
16.2 Market Restraints
16.3 Market Trends
16.4 Market Opportunity
16.5 Technological Road Map (Subject to Data Availability)
16.6 Product Life Cycle (Subject to Data Availability)
16.7 Customer and Buyer Behavior Analysis
- 16.7.1 Consumer Demographics and Target Audience Assessment
- 16.7.2 Consumer Purchase Behavior and Demand Assessment
- 16.7.3 Consumer Pricing Dynamics and Affordability Assessment
- 16.7.4 Digital Consumer Engagement and Online Adoption Analysis
- 16.7.5 Future Consumption Trends and Demand Evolution Analysis
- 16.7.6 Enterprise Procurement & Purchasing Behavior Analysis
- 16.7.7 Buyer Decision-Making & Purchase Influence Assessment
- 16.7.8 Customer Expectations & Service Experience Evaluation
- 16.7.9 Vendor Selection & Supplier Preference Analysis
- 16.7.10 Customer Retention & Loyalty Strategy Assessment
- 16.7.11 Pricing Sensitivity & Value Perception Analysis
- 16.7.12 Customer Segmentation & Demand Pattern Analysis
- 16.7.13 Relationship Management & Strategic Partnership Trends
16.8 Market Attractiveness Analysis
16.9 PESTEL Analysis
- 16.9.1 Political Factors
- 16.9.2 Economic Factors
- 16.9.3 Social Factors
- 16.9.4 Technological Factors
- 16.9.5 Legal Factors
- 16.9.6 Environmental Factors
16.10 Industrial Chain Analysis (Subject to Data Availability)
- 16.10.1 Industry Chain Analysis
- 16.10.2 Manufacturing Cost Analysis
- 16.10.3 Supply Side Analysis
  - 16.10.3.1 Raw Material Analysis
  - 16.10.3.2 Raw Material Procurement Analysis
  - 16.10.3.3 Raw Material Price Trend Analysis
16.11 Porter’s Five Forces Analysis
- 16.11.1 Bargaining Power of Suppliers
- 16.11.2 Bargaining Power of Buyers
- 16.11.3 Threat of New Entrants
- 16.11.4 Threat of Substitutes
- 16.11.5 Degree of Competition
16.12 Patent Analysis (Subject to Data Availability)
16.13 ESG Analysis

Segmentation Vaccine Type Analysis 2019 -2031, will provide market size split by Vaccine Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.

Chapter 17 Market Split by Vaccine Type Analysis 2022 - 2034

17.1 Pneumococcal Polysaccharide Vaccines
- 17.1.1 Europe Europe Pneumococcal Vaccines Market Size and Share by Pneumococcal Polysaccharide Vaccines 2022 - 2034
17.2 Pneumococcal Conjugate Vaccines
- 17.2.1 Europe Europe Pneumococcal Vaccines Market Size and Share by Pneumococcal Conjugate Vaccines 2022 - 2034

The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.

Chapter 18 Market Split by Product Type Analysis 2022 - 2034

18.1 Pneumovax 23
- 18.1.1 Europe Europe Pneumococcal Vaccines Market Size and Share by Pneumovax 23 2022 - 2034
18.2 Synflorix
- 18.2.1 Europe Europe Pneumococcal Vaccines Market Size and Share by Synflorix 2022 - 2034
18.3 Prevnar 13
- 18.3.1 Europe Europe Pneumococcal Vaccines Market Size and Share by Prevnar 13 2022 - 2034
18.4 Others
- 18.4.1 Europe Europe Pneumococcal Vaccines Market Size and Share by Others 2022 - 2034

Chapter 19 Market Split by Sector Analysis 2022 - 2034

19.1 Public
- 19.1.1 Europe Europe Pneumococcal Vaccines Market Size and Share by Public 2022 - 2034
19.2 Private
- 19.2.1 Europe Europe Pneumococcal Vaccines Market Size and Share by Private 2022 - 2034

Chapter 20 Market Split by Distribution Channel Analysis 2022 - 2034

20.1 Pharmacies
- 20.1.1 Europe Europe Pneumococcal Vaccines Market Size and Share by Pharmacies 2022 - 2034
20.2 Community clinics
- 20.2.1 Europe Europe Pneumococcal Vaccines Market Size and Share by Community clinics 2022 - 2034
20.3 Public Health agencies
- 20.3.1 Europe Europe Pneumococcal Vaccines Market Size and Share by Public Health agencies 2022 - 2034
20.4 Others
- 20.4.1 Europe Europe Pneumococcal Vaccines Market Size and Share by Others 2022 - 2034

Chapter 21 Europe Pneumococcal Vaccines Price Trend Analysis

21.1 Europe Europe Pneumococcal Vaccines Price Trend Analysis
21.2 Europe Europe Pneumococcal Vaccines Price Trend Analysis By Country

Chapter 22 Europe Pneumococcal Vaccines Import/Export Analysis

22.1 Europe Europe Pneumococcal Vaccines Market Import Data by Country (2019-2023)
22.2 Europe Europe Pneumococcal Vaccines Market Export Data by Country (2019-2023)

Chapter 23 Gap Analysis

23.1 Company Gap Assessment Analysis
23.2 Product & Service Portfolio Gap Analysis
23.3 Demand-Supply Imbalance Analysis
23.4 Market Opportunity & Unmet Needs Analysis
23.5 Technology Adoption & Digital Transformation Gap Analysis
23.6 Operational Efficiency & Process Gap Analysis
23.7 Infrastructure & Capacity Gap Analysis
23.8 Geographic Coverage & Distribution Gap Analysis
23.9 Investment Opportunity & Funding Gap Analysis
23.10 Pricing Structure & Margin Gap Analysis
23.11 Innovation & R&D Capability Gap Analysis
23.12 Policy, Compliance & Regulatory Gap Analysis
23.13 Customer Experience & Expectation Gap Analysis
23.14 Future Growth Opportunity Gap Analysis
23.15 Market Accessibility & Penetration Gap Analysis

Chapter 24 Strategy Analysis

24.1 Strategic Commercialization & Pricing Assessment

Chapter 25 Profitability and Gross Margin Analysis

25.1 Gross Margin Overview and Industry Profitability Trends
25.2 Regional Gross Margin Performance Analysis
25.3 Supply Chain and Distribution Impact on Gross Margins
25.4 Pricing Strategy and Value-Added Margin Assessment
25.5 Key Factors Influencing Gross Margin Variability
25.6 Future Gross Margin Outlook and Profitability Trends

Chapter 26 TAM Analysis

26.1 Europe Europe Pneumococcal Vaccines Market TAM Analysis

This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Europe Pneumococcal Vaccines market

Chapter 27 Research Findings

27.1 Key Takeaways
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

27.2 Analyst Point of View
27.3 Assumptions and Acronyms

Chapter 28 Research Methodology and Sources

28.1 Primary Data Collection
- 28.1.1 Steps for Primary Data Collection
  - 28.1.1.1 Identification of KOL
- 28.1.2 Backward Integration
- 28.1.3 Forward Integration
- 28.1.4 How Primary Research Help Us
- 28.1.5 Modes of Primary Research
28.2 Secondary Research
- 28.2.1 How Secondary Research Help Us
- 28.2.2 Sources of Secondary Research
28.3 Data Validation
- 28.3.1 Data Triangulation
- 28.3.2 Top Down & Bottom Up Approach
- 28.3.3 Cross check KOL Responses with Secondary Data
28.4 Data Representation

Research Methodology Implemented by Supriya Yadav and Team

1 Data Gathering
- 1.1 Research Design & Problem Structuring
  - 1.1.1 Identification of Research Objectives
  - 1.1.2 Market, Region, and Timeframe Definition
  - 1.1.3 Problem Decomposition & Hypothesis Development
  - 1.1.4 Mapping Data Requirements & Analytical Framework
- 1.2 Data Architecture & Multi-Source Intelligence
  - 1.2.1 Primary Research
    - 1.2.1.1 Manufacturers, distributors, and traders
    - 1.2.1.2 Procurement managers and industry buyers
    - 1.2.1.3 Technology providers and innovators
    - 1.2.1.4 Regulators and policy authorities
    - 1.2.1.5 Subject-matter experts and consultants
    - 1.2.1.6 End users across both B2B and B2C segments
  - 1.2.2 Secondary Research
    - 1.2.2.1 Public data sources
    - 1.2.2.2 Paid Data Sources
  - 1.2.3 Internal Knowledge Systems
2 Data Validation
- 2.1 Market Engineering & Quantitative Modelling
  - 2.1.1 Market Sizing and Forecasting Approach
    - 2.1.1.1 Market Sizing Techniques
    - 2.1.1.2 Forecasting Models
- 2.2 Economic Modelling Framework
  - 2.2.1 Cost Structure & Value Chain Economics
  - 2.2.2 Demand & Price Elasticity Analysis
  - 2.2.3 Supply–Demand Balance Assessment
  - 2.2.4 Economic Impact Assessment
- 2.3 Industry Structure, Competition & Technology Analysis
  - 2.3.1 Tools and Approaches Applied
- 2.4 Validation & Sensitivity Analysis
- 2.5 Insight Development & Recommendations
- 2.6 Transparent Documentation
3 Data Presentation

Preview Full Research Methodology

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.

Latest News about Europe Pneumococcal Vaccines Market

Sources from Pharma & Healthcare Industry

NEED ASSISTANCE?

WRITE US

CALL US

BOOK APPOINTMENT

WRITE AN EMAIL

info@cognitivemarketresearch.com

sales@cognitivemarketresearch.com

CALL US

USA: (+1) 929-659-6832

Europe and UK: (+44) 73-0721-4177

Asia Pacific: (+852) 24529464

Buy Now

Europe Pneumococcal Vaccines Market Analysis 2026

Europe Pneumococcal Vaccines Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Europe Pneumococcal Vaccines Industry Statistics

Europe Pneumococcal Vaccines Market Report Description

Introduction to the Europe Pneumococcal Vaccine Market

Europe Pneumococcal Vaccines Market Trends And Status Updates:

Competitive Landscape of the Pneumococcal Vaccine Market

Europe Pneumococcal Vaccines Market Segmentation Analysis from 2022 till 2034

Europe Pneumococcal Vaccines Market Share (%) by Vaccine Type in 2022-2034

Europe Pneumococcal Vaccines Market Share (%) by Product Type in 2022-2034

2022

2026

2034

Europe Pneumococcal Vaccines Sector Segment Analysis

Europe Pneumococcal Vaccines Distribution Channel Segment Analysis

Europe Pneumococcal Vaccines Country Analysis

Europe Pneumococcal Vaccines Market Share (%) by Country (2022-2034)

Author's Conclusion

Author's Detail

Frequently Asked Questions

Reviews

Europe Pneumococcal Vaccines Market Report Table of Content

Sample Format of Deliverables

2021

2025

2033

2021

2025

2033

Qualitative Analysis

Research Methodology Implemented by Supriya Yadav and Team

Latest News about Europe Pneumococcal Vaccines Market

Sources from Pharma & Healthcare Industry

NEED ASSISTANCE?

WRITE AN EMAIL

CALL US

Request Sample

Book Appointment